Nature Communications · 2016 · 79 citations · 29 references
Life SciencesCell BiologyMolecular BiologyMolecular Cell BiologyMolecular OncologyTumor ProgressionCancer Cell SignalingCancer ProgressionCell Membrane StructureCell-surface ReceptorsHer2-positive Breast CancerSignal Transduction In CancerBreast Cancer ProgressionCell Surface GlycoproteinsCell-cell MechanicsDeformationHer2 ExpressionHuman Epidermal Growth Factor Receptor 2 (Her2) ExpressionHuman Epidermal Growth Factor Receptor 2-Targeted TherapyProtein-induced Membrane Deformation
Breast cancers (BC) with HER2 overexpression (referred to as HER2 positive) progress more aggressively than those with normal expression. Targeted therapies against HER2 can successfully delay the progression of HER2-positive BC, but details of how this overexpression drives the disease are not fully understood. Using single-molecule biophysical approaches, we discovered a new effect of HER2 overexpression on disease-relevant cell biological changes in these BC. We found HER2 overexpression causes deformation of the cell membranes, and this in turn disrupts epithelial features by perturbing cell-substrate and cell-cell contacts. This membrane deformation does not require receptor signalling activities, but results from the high levels of HER2 on the cell surface. Our finding suggests that early-stage morphological alterations of HER2-positive BC cells during cancer progression can occur in a physical and signalling-independent manner.
29
Studies of the HER-2/ <i>neu</i> Proto-Oncogene in Human Breast and Ovarian Cancer
Dennis J. Slamon, William Godolphin, Lovell A. Jones et al. · Science · 1989 · 6.9K citations
Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
Matthew C. Franklin, Kendall D. Carey, F.F. Vajdos et al. · Cancer Cell · 2004 · 1.1K citations · Full text